Skip to content

Ultrasonic Viscoelasticity in the Auxiliary Diagnosis of Thyroid Nodules

A Prospective Study on the Auxiliary Diagnosis of the Nature of Thyroid Nodules Classified as ACR-TIRADS Category 4 or Higher by Ultrasonic Viscous Dispersion Coefficient

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113872
Enrollment
Unknown
Registered
2025-12-04
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid carcinoma

Interventions

Gold Standard:Surgical pathological results
Index test:Viscous Dispersion Coefficient

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 18 - 80 years old; 1.Thyroid nodules detected by ultrasonic examination, and meeting the indications for Fine-Needle Aspiration (FNA) (with reference to the relevant standards in Guidelines for the Diagnosis and Treatment of Thyroid Nodules and Differentiated Thyroid Cancer); 2.The nodules planned for aspiration, as evaluated by ultrasound, are classified as ARC-TIRADS 4A or above; 3.Voluntarily participating in this study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Complicated with severe dysfunction of important organs such as the heart, liver, and kidneys; 2.Suffering from mental illness and unable to cooperate with examinations and follow-ups; 3.Pregnant or lactating women; 4.A history of thyroid surgery or previous thyroid radiotherapy; 5.Having contraindications to ultrasonic examination (such as skin damage, severe allergies, etc.).

Design outcomes

Primary

MeasureTime frame
Viscous Dispersion Coefficient;

Secondary

MeasureTime frame
Basic information (including age, gender, height, weight, etc.);Routine ultrasound examination data;

Countries

China

Contacts

Public ContactLiu Long

Shanghai General Hospital

13817309541@163.com+86 13817309541

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026